NM_012120.3:c.4+262T>G
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_012120.3(CD2AP):c.4+262T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.254 in 151,142 control chromosomes in the GnomAD database, including 5,549 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Consequence
NM_012120.3 intron
Scores
Clinical Significance
Conservation
Publications
- focal segmental glomerulosclerosis 3, susceptibility toInheritance: AR, AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
- inherited focal segmental glomerulosclerosisInheritance: AD Classification: MODERATE Submitted by: ClinGen
- familial idiopathic steroid-resistant nephrotic syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -14 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_012120.3. You can select a different transcript below to see updated ACMG assignments.
Frequencies
GnomAD3 genomes AF: 0.254 AC: 38341AN: 151030Hom.: 5538 Cov.: 31 show subpopulations
GnomAD4 genome AF: 0.254 AC: 38373AN: 151142Hom.: 5549 Cov.: 31 AF XY: 0.263 AC XY: 19410AN XY: 73842 show subpopulations
Age Distribution
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at